Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CONAGRAF TM DURAPATITE CONES

K-Number: K820023 · 1982-02-24

ApplicantSterling Drug, Inc.
Decision Date1982-02-24
Product CodeLYC
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

CONAGRAF TM DURAPATITE CONES is the device name listed in this FDA 510(k) record. The listed applicant is Sterling Drug, Inc.. It received FDA 510(k) clearance on 1982-02-24 under 510(k) number K820023. The device is classified under product code LYC. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CONAGRAF TM DURAPATITE CONES?

CONAGRAF TM DURAPATITE CONES is a medical device that received FDA 510(k) clearance on 1982-02-24. The listed applicant is Sterling Drug, Inc.. The 510(k) number is K820023.

When did CONAGRAF TM DURAPATITE CONES receive FDA 510(k) clearance?

CONAGRAF TM DURAPATITE CONES received FDA 510(k) clearance on 1982-02-24, under 510(k) number K820023.

Who is the listed applicant for CONAGRAF TM DURAPATITE CONES?

The FDA 510(k) record lists Sterling Drug, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CONAGRAF TM DURAPATITE CONES?

The FDA product code for CONAGRAF TM DURAPATITE CONES is LYC.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Sterling Drug, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K901369GREEN LABEL BIOBRANE II AND RED LABEL BIOBRANE IIK896110BIOBRANE(R) IIK875275WINTHROP PHARMACEUTICALS CONTRAST MEDIA WARMERK840260PERIOGRAF DURAPATITE 40-60 MESHK820164EMPTY STERILE CARPUJECTK813257ALVEOGRAF DURAPATITE(18-40 MESH)

View all 9 devices →

Related Devices (Code: LYC)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K253317Cytrans™ ElashieldGC America, Inc.K253883Bonalive MaxillofacialBonalive , Ltd.K251818BONTREE PLUSHudens Bio Co., Ltd.K244006FG Bone Graft MFull Golden Biotech Co., Ltd.K243745FG Bone Graft BFull Golden Biotech CorporationK241186Synthetic Bone Graft ParticulateShenzhen Dazhou Medical Technology Co., Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑